Innovative Portfolio Otsuka Pharmaceutical specializes in developing innovative healthcare products focused on mental health and nephrology, presenting opportunities for partners offering advanced biotech solutions or digital health tools to enhance their R&D capabilities.

Global R&D Focus With 34 research institutes worldwide and a significant research investment of €2.0 billion in 2023, there is potential to collaborate on cutting-edge clinical trials, research technology, and innovative drug formulation solutions.

Emerging Markets Otsuka’s expansion across 32 countries indicates a growing footprint in diverse markets, creating opportunities to support their supply chain, regulatory compliance, and localized marketing strategies.

Technology Adoption Utilizing advanced tech stacks such as Amazon S3, Vue.js, and AI-focused initiatives like the NOW AI Conference, Otsuka shows interest in digital transformation, signaling a market for cloud solutions, AI integrations, and data analytics services.

Strategic Collaborations Participation in industry events and their focus on unmet medical needs, including multi-resistant tuberculosis and oncohematology, open doors for strategic partnerships in clinical research, diagnostics, and health data management.